Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1996 3
1997 10
1998 5
1999 11
2000 2
2001 4
2002 2
2004 1
2005 3
2006 3
2007 3
2008 1
2010 3
2011 7
2012 7
2013 6
2014 5
2015 8
2016 4
2017 5
2018 5
2019 5
2020 12
2021 14
2022 16
2023 1
Text availability
Article attribute
Article type
Publication date

Search Results

138 results
Results by year
Filters applied: . Clear all
Page 1
Antigen-specific vaccines for cancer treatment.
Tagliamonte M, Petrizzo A, Tornesello ML, Buonaguro FM, Buonaguro L. Tagliamonte M, et al. Hum Vaccin Immunother. 2014;10(11):3332-46. doi: 10.4161/21645515.2014.973317. Hum Vaccin Immunother. 2014. PMID: 25483639 Free PMC article. Review.
Virus-like Particles as Preventive and Therapeutic Cancer Vaccines.
Tornesello AL, Tagliamonte M, Buonaguro FM, Tornesello ML, Buonaguro L. Tornesello AL, et al. Among authors: tagliamonte m. Vaccines (Basel). 2022 Feb 2;10(2):227. doi: 10.3390/vaccines10020227. Vaccines (Basel). 2022. PMID: 35214685 Free PMC article. Review.
Phase I/II Multicenter Trial of a Novel Therapeutic Cancer Vaccine, HepaVac-101, for Hepatocellular Carcinoma.
Löffler MW, Gori S, Izzo F, Mayer-Mokler A, Ascierto PA, Königsrainer A, Ma YT, Sangro B, Francque S, Vonghia L, Inno A, Avallone A, Ludwig J, Alcoba DD, Flohr C, Aslan K, Mendrzyk R, Schuster H, Borrelli M, Valmori D, Chaumette T, Heidenreich R, Gouttefangeas C, Forlani G, Tagliamonte M, Fusco C, Penta R, Iñarrairaegui M, Gnad-Vogt U, Reinhardt C, Weinschenk T, Accolla RS, Singh-Jasuja H, Rammensee HG, Buonaguro L. Löffler MW, et al. Among authors: tagliamonte m. Clin Cancer Res. 2022 Jun 13;28(12):2555-2566. doi: 10.1158/1078-0432.CCR-21-4424. Clin Cancer Res. 2022. PMID: 35421231 Clinical Trial.
Neoantigens as potential vaccines in hepatocellular carcinoma.
Repáraz D, Ruiz M, Llopiz D, Silva L, Vercher E, Aparicio B, Egea J, Tamayo-Uria I, Hervás-Stubbs S, García-Balduz J, Castro C, Iñarrairaegui M, Tagliamonte M, Mauriello A, Cavalluzzo B, Buonaguro L, Rohrer C, Heim K, Tauber C, Hofmann M, Thimme R, Sangro B, Sarobe P. Repáraz D, et al. Among authors: tagliamonte m. J Immunother Cancer. 2022 Feb;10(2):e003978. doi: 10.1136/jitc-2021-003978. J Immunother Cancer. 2022. PMID: 35193931 Free PMC article.
Independent infections of porcine deltacoronavirus among Haitian children.
Lednicky JA, Tagliamonte MS, White SK, Elbadry MA, Alam MM, Stephenson CJ, Bonny TS, Loeb JC, Telisma T, Chavannes S, Ostrov DA, Mavian C, Beau De Rochars VM, Salemi M, Morris JG Jr. Lednicky JA, et al. Among authors: tagliamonte ms. Nature. 2021 Dec;600(7887):133-137. doi: 10.1038/s41586-021-04111-z. Epub 2021 Nov 17. Nature. 2021. PMID: 34789872 Free PMC article.
Immunotherapy in hepatocellular carcinoma.
Buonaguro L, Mauriello A, Cavalluzzo B, Petrizzo A, Tagliamonte M. Buonaguro L, et al. Among authors: tagliamonte m. Ann Hepatol. 2019 Mar-Apr;18(2):291-297. doi: 10.1016/j.aohep.2019.04.003. Epub 2019 Apr 25. Ann Hepatol. 2019. PMID: 31047849 Free article. Review.
Combinatorial immunotherapy strategies for hepatocellular carcinoma.
Tagliamonte M, Petrizzo A, Tornesello ML, Ciliberto G, Buonaguro FM, Buonaguro L. Tagliamonte M, et al. Curr Opin Immunol. 2016 Apr;39:103-13. doi: 10.1016/j.coi.2016.01.005. Epub 2016 Feb 4. Curr Opin Immunol. 2016. PMID: 26851637 Review.
Cellular prognostic markers in hepatitis-related hepatocellular carcinoma.
Petrizzo A, Mauriello A, Tornesello ML, Buonaguro FM, Tagliamonte M, Buonaguro L. Petrizzo A, et al. Among authors: tagliamonte m. Infect Agent Cancer. 2018 Mar 27;13:10. doi: 10.1186/s13027-018-0183-8. eCollection 2018. Infect Agent Cancer. 2018. PMID: 29599818 Free PMC article. Review.
Cellular prognostic markers in hepatocellular carcinoma.
Buonaguro L, Tagliamonte M, Petrizzo A, Damiano E, Tornesello ML, Buonaguro FM. Buonaguro L, et al. Among authors: tagliamonte m. Future Oncol. 2015;11(11):1591-8. doi: 10.2217/fon.15.39. Future Oncol. 2015. PMID: 26043213 Review.
Novel Molecular Targets for Hepatocellular Carcinoma.
Cavalluzzo B, Mauriello A, Ragone C, Manolio C, Tornesello ML, Buonaguro FM, Tvingsholm SA, Hadrup SR, Tagliamonte M, Buonaguro L. Cavalluzzo B, et al. Among authors: tagliamonte m. Cancers (Basel). 2021 Dec 28;14(1):140. doi: 10.3390/cancers14010140. Cancers (Basel). 2021. PMID: 35008303 Free PMC article.
138 results